Reliable change indexes for memory performance in schizophrenia as a means to determine drug-induced cognitive decline

Applied Neuropsychology

Volumn 10, Issue 2, 2003, Pages 115-120

  Moritz, Steffen ^a,c   Iverson, Grant L ^b   Woodward, Todd S ^b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Antipsychotics; Memory; Neuroleptics; Reliable change; Schizophrenia

Indexed keywords

PSYCHOTROPIC AGENT;

ADULT; ANTICHOLINERGIC EFFECT; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; LEARNING; LEARNING DISORDER; MALE; MEDICAL DECISION MAKING; MEMORY; MEMORY DISORDER; RELIABILITY; SCHIZOPHRENIA;

EID: 0037971495     PISSN: 09084282     EISSN: 15324826     Source Type: Journal    
DOI: 10.1207/S15324826AN1002_07     Document Type: Article

References (39)

1. Aleman, A., Hijman, R., de Haan, E. H. E, & Kahn, R. S. (1999). Memory impairment in schizophrenia: A meta-analysis. American Journal of Psychiatry, 156, 1358-1366.
2. Barr, W. B., & McCrea, M. (2001). Sensitivity and specificity of standardized neurocognitive testing immediately following sports concussion. Journal of the International Neuropsychological Society, 7, 693-702.
3. Buffett-Jerrott, S. E., & Stewart, S. H. (2002). Cognitive and sedative effects of benzodiazepine use. Current Pharmaceutical Design, 8(1), 45-58.
4. Carter, J., Thrasher, S., & Thomicroft, G. (1994). Cognitive impairment and clozapine. British Journal of Psychiatry, 164(1), 132-133.
5. Chelune, G. J., Naugle, R. I., Luders, H., Sedlak, J., & Awad, I. A. (1993). Individual change after epilepsy surgery: Practice effects and base-rate information. Neuropsychology, 7, 41-52.
6. Grace, J., Bellus, S. B., Raulin, M. L., Herz, M. I., Priest, B. L., Brenner, V., et al. (1996). Long-term impact of clozapine and psychosocial treatment on psychiatric symptoms and cognitive functioning. Psychiatric Services, 47(1), 41-45.
7. Green, M. F. (1996). What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry, 153(3), 321-330.
8. Hageman, W. J. J. M., & Arrindell, W. A. (1993). A further refinement of the reliable change (RC) index by improving the pre-post difference score: Introducing RC(ID). Behaviour Research and Therapy, 31, 693-700.
9. Hageman, W. J. J. M., & Arrindell, W. A. (1999a). Clinically significant and practical! Enhancing precision does make a difference. Reply to McGlinchey and Jacobson, Hsu, and Speer. Behaviour Research and Therapy, 37, 1219-1233.
10. Hageman, W. J. J. M., & Arrindell, W. A. (1999b). Establishing clinically significant change: Increment of precision and the distinction between individual and group level of analysis. Behaviour Research and Therapy, 37, 1169-1193.
11. Heaton, R. K., Temkin, N., Dikmen, S. Avitable, N., Taylor, M. J., Marcotte, T. D., et al. (2001). Detecting change: A comparison of three neuropsychological methods using normal and clinical samples. Archives of Clinical Neuropsychology, 16, 75-91.
12. Heubrock, D. (1992). Der Auditiv-Verbale Lerntest (AVLT) in der klinischen und experimentellen Neuropsychologie. Durchführung, Auswertung und Forschungsergebnisse [The Auditory-Verbal Learning Test (AVLT) in clinical and experimental neuropsychology. Administraton, evaluation, and research findings]. Zeitschrift für Differentielle und Diagnostische Psychologie, 3, 161-174.
13. Hinton-Bayre, A. D., Geffen, G. M., Geffen, L. B., McFarland, K. A., & Friis, P. (1999). Concussion in contact sports: Reliable change indexes of impairment and recovery. Journal of Clinical and Experimental Neuropsychology, 21, 70-86.
14. Hsu, L. M. (1989). Reliable changes in psychotherapy: Taking into account regression toward the mean. Behavioral Assessment, 11, 459-467.
15. Hsu, L. M. (1999). A comparison of three methods of identifying reliable and clinically significant client changes: Commentary on Hageman and Arrindell. Behaviour Research and Therapy, 37, 1195-1202.
16. Iverson, G. (1999). Interpreting change on the WAIS-III/WMS-III following traumatic brain injury. Journal of Cognitive Rehabilitation, 17, 16-20.
17. Iverson, G. I. (2001). Interpreting change on the WAIS-III/ WMS-III in clinical samples. Archives of Clinical Neuropsychology, 16, 183-191.
18. Iverson, G. L. (1998). Interpretation of Mini-Mental State Examination scores in community-dwelling elderly and geriatric neuropsychiatry patients. International Journal of Geriatric Psychiatry, 13, 661-666.
19. Iverson, G. L., & Green, P. (2001). Measuring improvement or decline on the WAIS-R in inpatient psychiatry. Psychological Reports, 89, 457-462.
20. Jacobson, N. S., Follette, W. C., & Revenstorf, D. (1984). Psychotherapy outcome research: Methods for reporting variability and evaluating clinical significance. Behavior Therapy, 15, 336-352.
21. Jacobson, & Revenstorf, D. (1988). Statistics for assessing the clinical significance of psychotherapy issues: Issues, problems, and new developments. Behavioral Assessment, 10, 133-145.
22. Jacobson, N. S., Roberts, L. J., Berns, S. B., & McGlinchey, J. B. (1999). Methods for defining and determining the clinical significance of treatment effects: Description, application, and alternatives. Journal of Consulting and Clinical Psychology, 67, 300-307.
23. Jacobson, N. S., & Truax, P. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59, 12-19.
24. Lee, M. A., Jayathilake, K., & Meltzer, H. Y. (1999). A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia. Schizophrenia Research, 37, 1-11.
25. Lehrl, S. (1995). Mehrfachwahl-Wortschatz-Intelligenztest: MWT-B (3rd ed.). Balingen: PERIMED-spitta.
26. Lezak, M. D. (1995). Neuropsychological assessment. (3rd ed.). Oxford, England: Oxford University Press.
27. Medalia, A., Gold, J., & Merriam, A. (1988). The effects of neuroleptics on neuropsychological test results of schizophrenics. Archives of Clinical Neuropsychology, 3, 249-271.
28. Meltzer, H.-Y., & McGurk, S. (1999). The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophrenia Bulletin, 25, 233-255.
29. Moritz, S. (2002). Cognitive dysfunctions. In D. Naber, M. Lambert, M. Krausz, C. Haasen, & D. Pickar (Eds.), Atypical neuroleptics in the treatment of schizophrenic patients (pp. 167-175). Bremen, Germany: Uni-Med.
30. Moritz, S., Heeren, D., Andresen, B., & Krausz, M. (2001). An analysis of the specifity and the syndromal correlates of verbal memory impairments in schizophrenia. Psychiatry Research, 101(1), 23-31.
31. Moritz, S., Krausz, M., Gottwalz, E., Lambert, M., Perro, C., Ganzer, S., et al. (2000). Cognitive dysfunction at baseline predicts symptomatic one-year outcome in first-episode schizophrenics. Psychopathology, 33, 48-51.
32. Moritz, S., Perro, C., Woodward, T. S., & Krausz, M. (2002). Subjective cognitive dysfunction in first-episode patients predicts symptomatic outcome: a replication. Psychopathology, 35, 367-368.
33. Ogles, B. M., Lambert, M. J., & Masters, K. S. (1996). Assessing outcome in clinical practice. Boston: Allyn & Bacon.
34. Saint-Cyr, J. A., Taylor, A. E., & Lang, A. E. (1993). Neuropsychological and psychiatric side-effects in the treatment of Parkinson's disease. Neurology, 43(12, Suppl. 6), S47-S52.
35. Speer, D. C. (1992). Clinically significant change: Jacobson and Truax (1991) revisited. Journal of Consulting and Clinical Psychology, 60, 402-408.
36. Speer, D. C., & Greenbaum, P. E. (1995). Five methods for computing significant individual client change and improvement rates: Support for an individual growth curve approach. Journal of Consulting and Clinical Psychology, 63, 1044-1048.
37. Spohn, H. E., & Strauss, M. E. (1989). Relation of antipsychotic and anticholinergic medication to cognitive functions in schizophrenia. Journal of Abnormal Psychology, 98, 367-380.
38. Sweeney, J. A., Keilp, J. G., Haas, G. L., & Weiden, P. J. (1991). Relationships between medication treatments and neuropsychological test performance in schizophrenia. Psychiatry Research, 37, 297-308.
39. Temkin, N. R., Heaton, R. K., Grant, I., & Dikmen, S. S. (2000). Reliable change formula query: Temkin et al. reply. Journal of the International Neuropsychological Society, 6, 364.